Presented by Integra LifeSciences
Integra LifeSciences, a worldwide leader in medical technology, has offered innovative solutions to wound care clinicians and patients for over 25 years. Their earliest product, Integra® Dermal Regeneration Template, was the first product FDA-approved with a claim of regeneration of dermal tissue. Currently, Integra’s expanded portfolio of wound care products represents over two decades of science and innovation in the development of collagen technology.
Join nationally renowned vascular surgeon, John Lantis, MD, for a review Integra’s Smart Solutions for serious chronic wounds. Familiarize yourself with the Science and Clinical Data behind Integra’s newest additions to their regenerative wound portfolio - Omnigraft™ Dermal Regeneration Matrix, a new PMA-approved product for the treatment of diabetic foot ulcers as well as PriMatrix® and PriMatirx Ag Antimicrobial, fetal bovine dermal collagen matrices for wound management.